He explained that NeuroVision Inc is a USA Delaware-registered company, founded in 1999. Company headquarters are located in Singapore, and the R&D, Sales and Marketing, and Operations are conducted by NeuroVision Pte Ltd, the Company's wholly-owned Singaporean subsidiary.
The Singapore Eye Research Institute (SERI) is NeuroVision's primary research and clinical partner. The Singapore National Eye Center (SNEC) is NeuroVision's first commercial provider of NeuroVision's treatments in Asia, and its reference centre. NeuroVision is best known for its programme designed to improve the vision of children with myopia.
Mr Ellenbogen explained that NeuroVision's NVCTM vision correction technology enhances eyesight without sugery or medication. It optimises the performance of the neural or "back end" of the visual system - nothing is changed optically. The technology has been developed through research focused solely on how the brain processes vision. Generally 30 to 40 sessions with a computer programme are required to yield positive results.
Dr Allan Fong of SERI is one of the clinical investigators of a new pilot study which is now in its formation. Dr Fong explained that the study will focus on AMD sufferers, who have reduced central vision. It will evaluate the efficacy of NeuroVisions NVCTM for AMD patients.
The study is now recruiting around 50 volunteers to participate in the study. Volunteers must be between 10 and 70 years old. Their eye pathology must be stable.
They must have best corrected vision ranging from 6/7.5 to 6/30. Participants will be given a course of NeuroVision treatment sessions (around 30 to 40 sessions in pace of 2-3 times a week) at the NeuroVision Centre located at SNEC. They will be followed up for 12 months after the treatment with quarterly vision tests. The treatment is free for those selected to participate in the pilot study.
During the lively Q and A, Mr Ellenbogen and Dr Fong explained that not all who apply will be selected. Persons will be required to be available to undergo the treatments without any breaks over a three-month period.
All interested individuals can call DEBBIE LOW at 6322-4502 for clarification, or to fix an appointment for screening. Debbie can also be reached at debbie.low.w.l@seri.com.sg. There are still places available, and MDS members who qualify are encouraged to volunteer.
No comments:
Post a Comment